---
title: "LKFT.US (LKFT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/LKFT.US/news.md"
symbol: "LKFT.US"
name: "LKFT.US"
parent: "https://longbridge.com/en/quote/LKFT.US.md"
datetime: "2026-05-16T03:51:43.048Z"
locales:
  - [en](https://longbridge.com/en/quote/LKFT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/LKFT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/LKFT.US/news.md)
---

# LKFT.US (LKFT.US) — Related News

### [RBC Capital Sticks to Its Hold Rating for Lakefront Biotherapeutics (LKFT)](https://longbridge.com/en/news/286254871.md)
*2026-05-13T11:47:42.000Z*
> RBC Capital analyst Brian Abrahams has maintained a Hold rating on Lakefront Biotherapeutics (LKFT) with a price target 

### [Galapagos Shareholders Approve Name Change to Lakefront Biotherapeutics and Broad Governance Overhaul](https://longbridge.com/en/news/284587561.md)
*2026-04-29T13:38:27.000Z*
> Galapagos NV shareholders approved a name change to Lakefront Biotherapeutics and a governance overhaul during their mee

### [Galapagos (GLPG) Expected to Announce Quarterly Earnings on Wednesday](https://longbridge.com/en/news/284495721.md)
*2026-04-29T05:07:05.000Z*
> Galapagos (NASDAQ:GLPG) is set to announce its Q1 2026 earnings on May 6, with analysts expecting a loss of $0.13 per sh

### [Short Interest in Galapagos NV (NASDAQ:GLPG) Expands By 20.4%](https://longbridge.com/en/news/283206270.md)
*2026-04-18T01:46:58.000Z*
> Galapagos NV (NASDAQ:GLPG) experienced a 20.4% increase in short interest in March, totaling 1,096,114 shares as of Marc

### [Galapagos (NASDAQ:GLPG) Stock Crosses Below 200 Day Moving Average   - Time to Sell?](https://longbridge.com/en/news/282003876.md)
*2026-04-08T08:37:46.000Z*
> Galapagos NV (NASDAQ:GLPG) shares fell below their 200-day moving average of $32.63, trading at $28.93. Analysts have mi

### [Galapagos Strikes New Gilead Deal to Co-Develop Gamgertamig and Unlock $500 Million for Strategic Moves](https://longbridge.com/en/news/281192727.md)
*2026-03-31T13:01:29.000Z*
> Galapagos has entered a binding framework agreement with Gilead Sciences related to Gilead's $1.675 billion acquisition